EU clears Kretinsky-led consortium taking control of Casino
From Nasdaq, Inc.: The European Commission has approved the consortium led by Czech billionaire Daniel Kretinsky to gain control of
Category: Markets
Preliminary data on early redemptions (prepayments)
From GlobeNewswire: Jyske Realkredit releases preliminary data on early redemptions (prepayments) for bonds issued, per the Capital Markets Act. The
Akoya Biosciences, Thermo Fisher Scientific Announce Deal To Deliver Spatial Multiomics Workflow
From Nasdaq: Akoya Biosciences Inc. (AKYA) has announced a partnership with Thermo Fisher Scientific to combine their RNA solutions to
Transaction in Own Shares
From GlobeNewswire: Endeavour Mining plc has announced its purchase of 157,286 of its ordinary shares. The lowest price paid per
Specialised Therapeutics Signs Deal With Ascendis For Commercialization Of 3 Endocrinology Therapies
From Nasdaq: Specialised Therapeutics Asia Pte Ltd. has signed an exclusive agreement with Danish company Ascendis Pharma A/S for distribution
TGS Announces Prefunding on 2D Multi-Client Seismic Project
From GlobeNewswire: TGS, PGS, and SLB have secured prefunding to expand seismic data coverage in the Sabah Basin, Malaysia. The
“First Five Days Indicator” – Myth or Market Magic for 2024?
From Barchart: The stock market saw an initial sell-off in 2024, sparking concerns about the market’s future direction. Additionally, the
Berkshire Hathaway And Haslam Family Resolve Dispute Over Pilot Travel Centers Stake
From Nasdaq: Berkshire Hathaway and Pilot Corp. have reached a full settlement in their Delaware litigation, cancelling a scheduled trial.
Sensex, Nifty Struggle For Direction In Early Trade
From Nasdaq: Indian shares were mixed on Monday as investors considered global market trends and anticipated strong economic growth in
Oil Prices Dip as Saudi Arabia Cuts Prices Amid Global Market Weakness
From Quiver Quantitative: Oil prices are declining, influenced by Saudi Aramco’s reduction in official prices. The price of Arab Light
Wall Street Doubles Down on Bonds
From Dow Jones & Company: Investors believe U.S. bonds are currently a good bet, with consensus on Wall Street that
Ultragenyx Pharma Sees FY23 Total Revenue Below View
From Nasdaq: Ultragenyx Pharmaceutical Inc. (RARE) predicts total revenue of $430-435 million for fiscal year 2023, falling slightly short of
Akoya Biosciences Deploys the MaxFuse Algorithm
From GlobeNewswire: MaxFuse is a new algorithm developed by Akoya Biosciences, in collaboration with Enable Medicine. This algorithm enables the
Asian Markets Mostly Lower | Nasdaq
From NASDAQ: Asian stock markets are trading mostly lower on Monday, despite slightly positive cues from Wall Street on Friday.
Akoya Biosciences Announces Preliminary Financial Results
From GlobeNewswire: Akoya Biosciences announced their preliminary unaudited revenue for the 4th quarter and full year of 2023. The expected
Traders Capitalize on High Yields with Confidence in Fed Cuts
From Quiver Quantitative: Bond traders have shown a bullish outlook amid speculation of upcoming Federal Reserve rate cuts, leading to
Castle Biosciences Expects FY23 Revenue To Exceed $210 Mln, Surpassing Previous Outlook
From Nasdaq, Inc.: Castle Biosciences Inc. (CSTL) is on track to generate over $210 million in revenue for fiscal year
RxSight, Inc. Announces Preliminary Unaudited Fourth
From GlobeNewswire: RxSight, an ophthalmic medical device company, announced preliminary unaudited financial results for the fourth quarter and full-year 2023.
Alnylam Pharma Announces Preliminary 2023 Global Net Product Revenue
From Nasdaq Inc.: Alnylam Pharmaceuticals Inc. reported 40% total TTR annual growth for ONPATTRO and AMVUTTRA in 2023, with global
Vincerx Pharma Announces Compelling Clinical Efficacy of
From GlobeNewswire: Vincerx Pharma, Inc. has announced promising clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination
China Stock Market May Stop The Bleeding On Monday
From Nasdaq: The China stock market has dropped for the second consecutive day by nearly 40 points due to the
Annexon Outlines 2024 Priorities with Late-Stage Clinical
From GlobeNewswire: In 2024, Annexon, Inc. will be reaching significant milestones in the development of potential treatments for various diseases.
U.S. Congress Agrees on Spending Cap Amid Policy Tensions
From Quiver Quantitative: U.S. congressional leaders have agreed on a $1.59 trillion spending cap for fiscal year 2024, reducing the
Singapore Stock Market May Regain 3,200-Point Level
From Nasdaq: The Singapore stock market ended a three-day slide and finished modestly higher, following gains in the financial and
Radio giant Audacy files for chapter 11 bankruptcy, as ad sales plunge
From Dow Jones & Company, Inc.: Radio and podcast company Audacy Inc. has filed for chapter 11 bankruptcy protection due